Carol holds a Bachelor of Science in Microbiology and a Master’s degree in Bacteriology. She began her career in academic research before transitioning to the medical device industry with Medtronic, where she specialized in Quality. She developed significant expertise in sterilisation and microbiology, supporting complex manufacturing processes and high-risk medical devices. Building on this technical foundation, she progressed into senior management roles with a focus on post-market quality and compliance, particularly within the Structural Heart business. Her career reflects a strong combination of scientific rigor and leadership in driving patient safety and regulatory excellence.

Shauna has over 15 years of senior finance experience, most recently serving as Vice President of Group Finance at Sebela Pharmaceuticals, a company involved in developing a women’s health medical device. Prior to this, she held key finance roles in the technology and manufacturing sectors. Shauna has had specific experience in driving operational efficiency, financial performance and managing mergers and acquisitions. She started her career in KPMG, she is a Chartered Accountant and a Fellow of the Institute of Chartered Accountants in Ireland.

Lucy has extensive experience leading medical device development programs. She worked as a cross-functional lead at Medtronic, managing R&D programs from concept to launch, including an early transcatheter aortic program. Additionally, she worked in Nypro Healthcare, managing multiple complex, cross-functional, global projects developing drug delivery devices for top tier pharmaceutical clients and in a CRO, ICON PLC, where she developed an understanding of clinical trials. She holds a degree in Mechanical Engineering from University College Dublin, a PhD in Biomedical Engineering from University of Limerick and a Diploma in Project Management from University College Cork.

Helen is a highly experienced leader of Regulatory, Clinical and Quality. Helen previously served in leadership roles in both start-ups (TriFlo Cardiovascular and Cephea Valve Technologies, acquired by Abbott) and multinationals (Abbott and Boston Scientific) across the full product development lifecycle in the structural heart space. Helen holds a BSc. in Industrial Chemistry from the University of Limerick and started her career in Pharma prior to discovering her passion for Regulatory Affairs with roles of increasing responsibility at Boston Scientific. During this time Helen relocated to the US and is based on the west coast.

Gavin is an R&D Leader with over a decade’s experience in bringing different technologies through from concept to clinical study and commercialization. Prior to joining CroíValve, Gavin worked in Medtronic where he held various People, Project and Technical Leadership roles. He contributed to the development and commercialization of Coronary Stent Delivery Systems and Transcatheter Aortic Valve Delivery Systems. More recently, he led the R&D efforts of a novel TransCatheter Mitral Valve Delivery System from Concept to Clinical Studies following the acquisition of a start up company. Gavin was awarded the honour of Medtronic Technical Fellow for his various technical contributions within the company. Additionally, he spent time in Fisher and Paykel Healthcare in New Zealand as an R&D Engineer where he supported the design and clinical assessment of a novel airway humidification device for the support of patients on ventilation. Gavin holds a B.E. in Biomedical Engineering from NUI Galway, is a certified Project Management Professional from the PMI Institute and has 9 US Granted Patents to his name, with others pending.

Martin is a consultant Interventional Cardiologist in St Vincent’s University Hospital and Blackrock Clinic with in-depth knowledge of the disease state and percutaneous methodologies to treat cardiovascular disease. He completed an interventional cardiology fellowship at the Cleveland Clinic, and has led the development of percutaneous valve therapies in Ireland, performing the first TAVI implant in Ireland in 2008. He acts as an expert reviewer for the Irish Health Products Regulatory Authority. He has filed multiple patents for cardiovascular devices and first patented the CroíValve concept in 2014. He studied medicine at UCD, completed an MSc in Cardiology at Trinity College and was awarded a PhD in Thrombosis for his research on platelet biology and thrombosis at the Royal College of Surgeons in Ireland in 2001.